Sorafenib and its tosyl-ate salt: A multikinase inhibitor for treating cancer

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 67, Issue 1, 2011, Pages

  Ravikumar, K ^a   Sridhar, B ^a   Bhujanga Rao, A K S ^b   Pulla Reddy, M ^b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b NATCO   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ORIENTATION; BLOOD SUPPLY; CARBOXAMIDES; FREE BASE; MALIGNANT CANCERS; METHYLPYRIDINE; PYRIDINE-2; PYRIDINIUM; SORAFENIB; TERMINAL GROUPS; TRIFLUOROMETHYL; ZIGZAG CHAINS;

HYDROGEN; HYDROGEN BONDS; O RINGS; PYRIDINE;

CONFORMATIONS;

TRIFLUORO;

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; ENZYME INHIBITOR; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; SORAFENIB; TOLUENESULFONIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; HUMAN; HYDROGEN BOND; NEOPLASM; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; HUMANS; HYDROGEN BONDING; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NEOPLASMS; PROTEIN KINASE INHIBITORS; PYRIDINES; TOSYL COMPOUNDS;

EID: 78651061814     PISSN: 01082701     EISSN: 01082701     Source Type: Journal    
DOI: 10.1107/S0108270110047451     Document Type: Article

References (21)

1. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalow, I. N. & Bourne, P. E. (2000). Nucleic Acids Res. 28, 235-242.
2. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
3. Brandenburg, K. & Putz, H. (2005). DIAMOND. Release 3.0c. Crystal Impact GbR, Bonn, Germany.
4. Bruker (2001). SAINT (Version 6.28a) and SMART (Version 5.625). Bruker AXS Inc., Madison, Wisconsin, USA.
5. Escudier, B. et al. (2007). New Engl. J. Med. 356, 125-134.
6. Etter, M. C. (1990). Acc. Chem. Res. 23, 120-126.
7. Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.
8. Ferrara, N., Hillan, K. J., Gerber, H. P. & Novotny, W. (2004). Nat. Rev. Drug Discov. 3, 391-400.
9. Ferrara, N. & Kerbal, R. S. (2005). Nature (London), 438, 967-974.
10. Holmes, R., Roberts, O. L., Thomas, A. M. & Cross, M. J. (2007). Cell. Signal. 19, 2003-2012.
11. Kane, R. C., Farrell, A. T., Madabushi, R., Booth, B., Chattopadhyay, S., Sridhara, R., Justice, R. & Pazudur, R. (2009). Oncologist, 14, 95-100.
12. Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
13. Namboodiri, H. V., Bukhtiyarova, M., Ramcharan, J., Karpusas, M., Lee, Y. & Springman, E. B. (2010). Biochemistry, 49, 3611-3618.
14. Ravikumar, K. & Sridhar, B. (2009). Acta Cryst. C65, o502-o505.
15. Ravikumar, K. & Sridhar, B. (2010). Acta Cryst. C66, m35-m39.
16. Ravikumar, K., Sridhar, B., Krishnan, H. & Singh, A. N. (2008). Acta Cryst. C64, o15-o17.
17. Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
18. Simard, J. R., Getlik, M., Grutter, C., Pawar, V., Wulfert, S., Rabiller, M. & Rauh, D. (2009). J. Am. Chem. Soc. 131, 13286-13296.
19. Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Jones, C. M., Marshall, C. J., Springer, C. J., Barford, D. & Marais, R. (2004). Cell, 116, 855-867.
20. Wilhelm, S. M. et al. (2004). Cell Res. 64, 7099-7109.
21. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. & Holash, J. (2000). Nature (London), 407, 242-248.